Literature DB >> 23202450

Brockman, M.A., et al., Human Leukocyte Antigen (HLA) Class I Down-Regulation by Human Immunodeficiency Virus Type 1 Negative Factor (HIV-1 Nef): What Might We Learn From Natural Sequence Variants? Viruses 2012, 4, 1711-1730.

Philip Mwimanzi1, Tristan J Markle, Takamasa Ueno, Mark A Brockman.   

Abstract

In the original manuscript, the text in figure 1 is illegible. Furthermore, there is an unnecessary carriage return (page 1716, ~line 18) "crystallographic ... methods".

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23202450      PMCID: PMC3497038          DOI: 10.3390/v4102014

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


In the original manuscript, the text in figure 1 is illegible. Furthermore, there is an unnecessary carriage return (page 1716, ~line 18) "crystallographic ... methods". “…The N-terminal anchor domain of Nef is required for membrane association and localization into detergent-insoluble “lipid rafts” [77], while the central core encodes numerous protein interaction and intracellular trafficking motifs that contribute differentially to diverse Nef functions [78]. The central core domain of Nef adopts a stable tertiary fold, permitting its early characterization using both NMR and X-ray crystallographic methods [79,80]. Our understanding of Nef-mediated HLA down-regulation has been significantly enhanced by the recently reported crystal structure of Nef protein in complex with the MHC-I cytoplasmic domain and the μ1 subunit of the clatherin AP1 complex [76].” The correct figure should be: Presentation of viral peptide antigens by Human Leukocyte Antigen (HLA) class I. Human immunodeficiency virus type 1 (HIV-1) proviral gene expression, including RNA transcription (a) and protein translation (b); generates functional viral proteins (c) as well as truncated or mis-folded proteins that are degraded by the cellular proteasome complex to form short antigenic peptides (d); These peptides are transported from the cytoplasm into the endoplasmic reticulum (ER) (e) where they can be loaded onto HLA-I molecules.Peptide/HLA complexes traffic from the ER through the Golgi and secretory vesicle (SV) network to the plasma cell membrane, where the peptide antigens are presented to circulating cytotoxic T lymphocytes (CTL) (f); The viral Nef protein shuttles HLA molecules located at the cell surface or within the trans-Golgi network into lysosomal compartments (g); where they are degraded.In the absence of Nef-mediated HLA down-regulation, antigen-specific CTL respond to stimulation by releasing cytotoxic molecules, including perforin and granzymes, resulting in elimination of the virus-infected cell (h).
  1 in total

Review 1.  Human leukocyte antigen (HLA) class I down-regulation by human immunodeficiency virus type 1 negative factor (HIV-1 Nef): what might we learn from natural sequence variants?

Authors:  Philip Mwimanzi; Tristan J Markle; Takamasa Ueno; Mark A Brockman
Journal:  Viruses       Date:  2012-09-24       Impact factor: 5.048

  1 in total
  1 in total

1.  Pharmacologic HIV-1 Nef blockade promotes CD8 T cell-mediated elimination of latently HIV-1-infected cells in vitro.

Authors:  Shariq Mujib; Aamir Saiyed; Saleh Fadel; Ardalan Bozorgzad; Nasra Aidarus; Feng Yun Yue; Erika Benko; Colin Kovacs; Lori A Emert-Sedlak; Thomas E Smithgall; Mario A Ostrowski
Journal:  JCI Insight       Date:  2017-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.